Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Amortizatization of Intangibles (2020 - 2025)

Beauty Health (SKIN) has disclosed Amortizatization of Intangibles for 6 consecutive years, with $6.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Amortizatization of Intangibles rose 32.67% to $6.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $17.7 million, a 12.48% decrease, with the full-year FY2024 number at $19.5 million, down 6.55% from a year prior.
  • Amortizatization of Intangibles was $6.7 million for Q3 2025 at Beauty Health, up from $3.6 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $13.3 million in Q4 2021 to a low of -$5.2 million in Q3 2021.
  • A 5-year average of $4.6 million and a median of $4.5 million in 2023 define the central range for Amortizatization of Intangibles.
  • Biggest YoY gain for Amortizatization of Intangibles was 170.61% in 2022; the steepest drop was 71.5% in 2022.
  • Beauty Health's Amortizatization of Intangibles stood at $13.3 million in 2021, then plummeted by 71.5% to $3.8 million in 2022, then skyrocketed by 30.69% to $5.0 million in 2023, then dropped by 14.72% to $4.2 million in 2024, then soared by 58.94% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Amortizatization of Intangibles are $6.7 million (Q3 2025), $3.6 million (Q2 2025), and $3.2 million (Q1 2025).